XCancer

[68Ga]Ga DOTA-5G as a Diagnostic Imaging Agent for Metastatic/Advanced Invasive Lobular Breast Cancer (LBC)

Description:

This is a prospective study using [68Ga]Ga DOTA-5G PET/CT imaging in patients diagnosed with metastatic/advanced invasive lobular breast cancer (LBC).

Sponsor:

University of California, Davis

Contacts:

Julie Sutcliffe, PhD

jlsutcliffe@ucdavis.edu

916-734-5536

Government Study Link:

NCT07020806 - Click here to see study on

ClinicalTrials.gov

[68Ga]Ga DOTA-5G

Isotope(s):
Target(s):
  • αvβ6
Ligand: Peptides
Chelator: DOTA
XCancer

© 2021 XCancer Software LLC

Contact XCancer: 402-991-8468